3rd Apr 2024

NICE recommends the Genedrive® CYP2C19-ID Kit

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that the...

20th Dec 2023

Initial overseas orders of the Genedrive® MT-RNR1 ID Kit

genedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, announces that ini...

4th Dec 2023

Royal Sussex County Hospital, Brighton adopts the Genedrive® MT-RNR1 ID Kit for routine use Further expansion of hearing loss test into the NHS

genedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, announces the Gene...